Page last updated: 2024-10-26

etilefrine and Cancer of Pancreas

etilefrine has been researched along with Cancer of Pancreas in 2 studies

Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koga, C1
Murakami, M1
Shimizu, J1
Yasuyama, A1
Matsumura, T1
Takata, A1
Kameda, C1
Kawabata, R1
Hirota, M1
Noura, S1
Hasegawa, J1
Jans, B1
Dusart, D1

Other Studies

2 other studies available for etilefrine and Cancer of Pancreas

ArticleYear
[A Case of Successful Management of Postoperative Chylous Ascites by Combination Therapy with Octreotide and Etilefrine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:3

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chylous Ascites; Drainage; Etilef

2018
[Thrombosis of both carotid arteries, arterial hypotension and cancer of the pancreas].
    Bruxelles medical, 1979, Volume: 59, Issue:10

    Topics: Aged; Carotid Artery Thrombosis; Ethanolamines; Etilefrine; Humans; Hypotension; Male; Mephentermine

1979